DENDRITE GIVES SHANGHAI SINE MEDICINE COMPANY THE ABILITY TO MEET THE UNIQUE NEEDS OF CHINESE PHARMACEUTICAL MARKET

A A

Dendrite International, Inc., a leading provider of pharmaceutical industry solutions, today announced a comprehensive three-year agreement to provide SINE Pharmaceutical Company Co., Ltd, a subsidiary of Shanghai Pharmaceutical Group Co., Ltd (SPGC) and pioneer in China's growing pharmaceutical market, with components of Dendrite's Sales Solutions.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060602005079&newsLang=en)